Vertex Pharmaceuticals, Inc. (VRTX)

467.35 +6.21 (+1.35%) USD  |  NASDAQ  |  Jan 22, 16:00
466.80 -0.55 (-0.12%) Pre-Market: 09:09
More

Vertex Pharmaceuticals Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade